|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Allergy Clinic, Boston Dispensary, and the Allergy-Pulmonary Disease Service, Pratt Clinic — New England Center Hospital, Department of Medicine, Tufts University School of Medicine
Theophylline glyceryl guaiacolate (Quibron) was administered to 50 patients with bronchial asthma, the large majority of whom were under observation for weeks to months. The compound was taken orally as needed in daily doses of 10 ml. to 45 ml. or more. Theophylline glyceryl guaiacolate is an effective oral bronchodilator agent applicable to mild or severe cases of asthma. The only unpleasant side effect noted was nausea; this was minimal and posed no problem.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |